По вашему запросу найдено документов: 28

Страница 2 из 3

factors for re-exacerbation and death from BA were identified. © 2023, Russian Open Medical Journal.

of therapeutic biomolecules to their target is a challenging issue, which can be solved by innovations in drug

in lipopolysaccharide (LPS)-challenged J774A.1 cells. Compounds 19, 20, and 39 potently reduced the release of IL-6

of recurrent serious ischemic events despite standard medical therapy, has been clinically challenging. A

number: DRKS00027302. © Author(s) (or their employer(s)) 2023. No commercial re-use. See rights

pose challenges for early DNA diagnosis. To comprehensively address this problem, it is essential

Роботическая реконструкция желчных протоков после ятрогенного повреждения

Клинический случай психического расстройства на фоне новой коронавирусной инфекции

Пути уменьшения инвазии при лечении холецистита у пациентов с избыточной массой тела

Предикторы первично-множественных злокачественных новообразований. Обзор литературы

Страница 2 из 3